<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>PuSH - HMGU Publikationen</title>
    <link>https://push-zb.helmholtz-munich.de</link>
    <description>
    PuSH - Publikationen-Server des Helmholtz Zentrums München
    </description>
    <language>de-de</language>

    <item>
      <title><![CDATA[Franceschi, E.* et al. EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol. 20, e715-e728 (2019)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=57538&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=57538&amp;la=de</guid>
      <pubDate>Mon, 09 Dec 2019 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Psallidas, I.* et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): A multicohort analysis. Lancet Oncol. 19, 930-939 (2018)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=53664&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=53664&amp;la=de</guid>
      <pubDate>Fri, 29 Jun 2018 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Guinney, J.* et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: Development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncol. 18, 132-142 (2017)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49973&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=49973&amp;la=de</guid>
      <pubDate>Wed, 23 Nov 2016 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Pastore, A.* et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: A retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 16, 1111-1122 (2015)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=46558&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=46558&amp;la=de</guid>
      <pubDate>Wed, 12 Aug 2015 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Issels, R.D. et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 11, 561-570 (2010)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1206&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=1206&amp;la=de</guid>
      <pubDate>Thu, 29 Jul 2010 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Landi, M.T.* et al. GPC5 rs2352028 variant and risk of lung cancer in never smokers. Lancet Oncol. 11, 714-716 (2010)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5157&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=5157&amp;la=de</guid>
      <pubDate>Tue, 12 Oct 2010 00:00:00 +0000</pubDate>
    </item>
    </channel>
</rss>